Instrumentation (02.17.10)
Instrumentation (02.17.10)

Instrumentation (02.17.10)
Miscellaneous Diseases (02.16.10)
Reactive Lymphocytes (02.11.10)
Myeloproliferative Disorders (02.10.10)
Chronic Lymphoblastic Leukemias (02.09.10)
Acute Lymphoblastic Leukemias (02.08.10)
Acute Leukemias 2 (02.04.10)
This lecture comprehensively covers myelodysplastic syndromes (MDS), discussing types like 5Q- syndrome and therapy-related MDS, along with their prognosis and management, including supportive care and stem cell transplants. It then delves into acute myeloid leukemias (AML), detailing the FAB and WHO classifications, specific subtypes (M0, M1, M2, M3), their unique morphological and cytogenetic features (e.g., 8;21 and 15;17 translocations), and the groundbreaking impact of treatments like retinoic acid for M3. The episode emphasizes diagnostic criteria, pathogenesis, and the evolution of understanding these complex hematologic disorders.
Myelodysplastic Syndrome (02.02.10)
Intro to Leukemia (02.01.10)
Hemolytic Anemia 2 (01.28.10)
Hemolytic Anemia 1 (01.27.10)
Hemoglobinopathies (01.26.10)
Normocytic Anemia (01.25.10)
Thalassemia 2 and Macrocytic Anemia (01.21.10)
Microcytic Anemia 3 and Thalassemia (01.20.10)
Microcytic Anemia 2 (01.19.10)
Leukocyte 4 and Microcytic Anemia (01.14.10)
Leukocyte 3 (01.13.10)
Leukocyte 2 (01.12.10)
Leukocyte 1 (01.11.10)
RBC Abnormalities (01.07.10)
Hematopoiesis 3 (01.06.10)
Hematopoiesis 2 (01.05.10)
Hematopoiesis 1 (01.04.10)